期刊文献+

组织因子启动子-1208 I/D基因多态性与静脉血栓栓塞的相关性研究 被引量:2

Correlation Analysis of Tissue Factor Promotor Polymorphism-1208I/D and Venous Thromboembolism
下载PDF
导出
摘要 本研究旨在探讨组织因子启动子-1208I/D基因多态性与静脉血栓栓塞(venous thromboembolism,VTE)的相关性。采用聚合酶链反应及DNA测序,对96例深静脉血栓(deep venous thrombosis,DVT)患者、14例肺栓塞(pulmonary embolism,PE)患者和59例健康人进行组织因子(tissue factor,TF)基因启动子序列-1208位点基因多态性分析。结果表明:该位点的基因变异为18bp碱基的插入,存在D/D、I/D、I/I三种基因型,基因型分布在对照组分别为D/D型67.8%,I/D型25.4%,I/I型6.8%,DVT组分别为D/D62.5%,I/D29.8%,I/I8.3%,PE组分别为D/D57.1%,I/D35.7%,I/I7.1%;D等位基因频率和I等位基因频率在对照组分别为80.5%、19.5%,DVT组分别为77.1%、22.9%,PE组分别为75.0%、25.0%。基因型分布和等位基因频率在各组间的差异无统计学意义。结论:TF启动子-1208I/D基因多态性与VTE的发病没有显著相关性,该基因可能不是中国汉族人VTE的易感基因。TF基因多态性有待深入研究。 The study was aimed to investigate the correlation of tissue factor promotor polymorphism -1208L/D with the venous thromboembolism in patients. Tissue factor promotor polymorphism -1208 was detected by polymerase chain reaction (PCR) and DNA sequencing in 96 cases of DVT, 14 cases of PE and 59 nonthrombosis normal individuals. The results showed that the allele containing a 18-bp nucleotides insertion at -1208. 67.8% of normal individuals exhibited D/D, 25.4% were heterozygous I/D, and 6.8% were homozygous for I/I. DVT group and PE group exhibited a similar distributions(62.5% D/D, 29.8% L/D, 8.3% L/I and 57.1% D/D, 35.7% L/D, 7.1% L/I). The allele frequencies of D and the allele frequencies of I in the normal control, DVT and PE groups were 80.5% ,77.1%, 75.0% and 19.5% ,22.9%, 25.0% respectively. There was no significant difference in the TF-12081/D genotype frequency be- tween the groups of patients and normal individuals. In conclusion, there is no correlation of the tissue factor promotor polymorphism -1208L/D in the patients with venous thromboembolism. The gene of promoter -1208 I/D may not be a major susceptible gene of VTE in Chinese Han. Further investigations would be necessary to define accurately tissue factor gene polymorphisms.
出处 《中国实验血液学杂志》 CAS CSCD 2009年第4期1036-1039,共4页 Journal of Experimental Hematology
基金 山西省归国留学人员基金 编号2005069
关键词 组织因子 基因多态性 静脉血栓栓塞 tissue factor gene polymorphisms venous thromboembolism
  • 相关文献

参考文献11

  • 1肺血栓栓塞症的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2001,24(5):259-264. 被引量:1838
  • 2Donahue BS, Byrne DW, Gailani D, et al. Tissue factor and platelet glycoprotein Ib-α alleles are associated with age at first coronary bypass operation. Anesthesiology,2003 ; 99 : 1287 - 1294.
  • 3Falati S, Gross P, Merrill SG,et al. Real time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med,2002 ;8 : 1175 - 1181.
  • 4Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vase Biol, 1995 ;15:612 -621.
  • 5Mechtcheriakova D, Schabbauer G, Lucerna M, et al. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J, 2001 ; 15:230 -242.
  • 6Terry CM, Kling SJ, Cheang KI. et al. Polymorphisms in the 5′-UTR of the tissue factor gene are associated with altered expression in human endothelial cells. J Thromb Haemost, 2004;2:1351 -1358.
  • 7程克斌,王乐民,胡莺,郜恒骏.肺栓塞患者血浆凝血因子基因表达谱的差异[J].上海医学,2008,31(6):381-384. 被引量:4
  • 8郑红,贺颖,陈辉,齐华,连建华,董子明.凝血因子基因突变及MTHFR/C677T基因多态性与深静脉血栓形成的关系[J].中华血液学杂志,2006,27(3):197-198. 被引量:9
  • 9Aruaud E, Barbalat V, Nicaud V, et al . Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Temoins de 1 ′Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol, 2000 ; 20 : 892 - 898.
  • 10Slomiany BA, D′Arigo KL, Kelly MM, et al. C/EBP alpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol, 2000; 20:5986 -5997.

二级参考文献25

  • 1王美堂,李强,韩凤来,姚小鹏.血浆叶酸、同型半胱氨酸水平及亚甲基四氢叶酸还原酶基因突变与静脉血栓栓塞症[J].中华内科杂志,2004,43(8):591-594. 被引量:15
  • 2Frosst P,Blom H J,Mulinare J,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylene-tetrahydrofolate reductase.Nat Genet,1995,10:111-117.
  • 3Ridker PM,Hennekens CH,Lindpaintner K,et al.Mutation in the gene coding for coagulation factor Ⅴ and the risk of myocardial infarction,stroke,and venous thrombosis in apparently.N Engl J Med,1995,6:912-916.
  • 4Poort SR,Rosendaal FR,Reitsma PH,et al.A common genetic variation in the 3 '-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis.Blood,1996,88:3698-3702.
  • 5Franco RF,Pazin-Filho A,Tavella MH,et al.Factor ⅩⅢ val34leu and the risk of myocardial infarction.Haematologica,2000,85:67-71.
  • 6Soria JM,Almasy L,Souto JC,et al.Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis.Blood,2000,95:2780-2785.
  • 7Zivelin A,Rosenberg N,Fairer S,et al.A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.Blood,1998,92:1119-1124.
  • 8Zheng H,Tzeng CC,Butt C,et al.An extremely low prevalence of factor Ⅴ Leiden,F Ⅱ G20210A and FXⅢV34L in Taiwan Chinese population.Thromb Haemost,2002,87:1081-1082.
  • 9Chunilal S D, Eikelboom J W, Attia J, et al. Does this patient have pulmonary embolism? JAMA, 2003, 290 2849-2858.
  • 10Fedullo P F, Tapson V F. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med, 2003, 349: 1247-1256.

共引文献1847

同被引文献28

  • 1姜剑军,张柏根,张皓.中国汉族深静脉血栓形成患者与组织因子途径抑制物基因多态性的关系[J].中华实验外科杂志,2005,22(6):676-677. 被引量:3
  • 2韩轩茂,任景芳,郝斌,曹文东,刘秀娥,侯丽虹,郭志萍,于斌,王学峰,丁秋兰,杨林花.静脉血栓栓塞症患者活化蛋白C抗性及凝血因子Ⅴ活性和基因多态性研究[J].中国实验血液学杂志,2007,15(3):612-616. 被引量:9
  • 3DelGiudice LA,White GA.The role of tissue factor and tissue factor pathway inhibitor in health and disease states[J].J Vet Emerg Crit Care (San Antonio),2009;19(1):23-9.
  • 4Dahm A,Van Hylckama Vlieg A,Bendz B,et al.Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis[J].Blood,2003;101(11):4387-92.
  • 5Bajaj MS,Birktoft JJ,Steer SA,et al.Structurc and biology of tissue factor pathway inhibitor[J].Thromb Hacmost,2001;86(4):957-72.
  • 6Bajaj MS,Tyson DR,Steer SA,et al.Role of GATA motifs in tissue factor pathway inhibitor gene expression in malignant cells[J].Thromb Res,2001;101(3):203-11.
  • 7Golino P.The inhibitor of the tissue factor:factor VⅡ pathway[J].Thromb Res,2002;106(3):257-65.
  • 8Piro O,Broze GJ Jr.Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding circulation[J].Circulation,2004;110(23):3567-72.
  • 9Lockett JM,Mast AE.Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor[J].Biochemistry,2002; 41(15):4989-97.
  • 10Lu G,Broze GJ Jr,Krishnaswamy S.Formation of factors Ⅸa and Ⅹa by the extrinsic pathway:differential regulation by tissue factor pathway inhibitor and antithrombin Ⅲ[J].J Biol Chem,2004;279(17):17241-9.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部